Fluvastatin viable option for preventing cardiac events

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1445, 2004-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluvastatin viable option for preventing cardiac events

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Fluvastatin: efficacy and safety in reducing cardiac events

By Chan Mark Y   Lee Chi Hang  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1883-1895

Informa Healthcare

Access to resources Recommend Favorite

An Economic Evaluation of Fluvastatin used for the Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention in the UK

By Scuffham P.A.   Chaplin S.  

PharmacoEconomics, Vol. 22, Iss. 8, 2004-01 ,pp. : 525-535

Adis International

Access to resources Recommend Favorite

Fluvastatin

By Lawrence JM   Reckless JPD  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 11, 2002-11 ,pp. : 1631-1641

Informa Healthcare

Access to resources Recommend Favorite

Rectal quinine a viable option in children with malaria

By  

Inpharma, Vol. 1, Iss. 1537, 2006-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite